# Nutrien Ltd. share price today (Nutrien Ltd., NTR)

> Nutrien Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. NTR · Materials · Agricultural Inputs · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ntr

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $69.32 (+27.3% in a year)
- P/E: 13.9× (lower than 57% of the last 4.6 years)
- Revenue (Jun 2026): $10.6 B (+4.0% on a year ago)
- Profit (Jun 2026): $1.2 B (−0.6% on a year ago)
- Operating margin: 17.5% (−0.3 points on a year ago)
- ROE: 9%, FY25
- ROIC: 7.4%, against a 8.7% cost of capital: −1.3 points

The main question: yearly earnings per share moved +242.6% while the share price moved +27.3%. ## What is the Nutrien Ltd. share price today? Nutrien Ltd.'s share price was $69.32 at the close on 3 November 2026. It has been moving sideways for 3 weeks. That is 2.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $56 and $83, and at that close it sat 49% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. Over the last 8.8 years the share price moved +24% while the S&P 500 moved +176%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Nutrien Ltd. pay? Nutrien Ltd. paid $2.19 per share over the last four reported quarters. The most recent declaration was $0.55 for Jun 2026. At today's price of $69.32 that is a yield of 3.16%, based on dividends already paid, not a forecast. ## Which stock lists is Nutrien Ltd. on? Nutrien Ltd. is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Nutrien Ltd. profitable? Nutrien Ltd. earned $1.2 B of net profit in the Jun 2026 quarter, −0.6% on the same quarter a year earlier. Full-year FY25 profit was $2.3 B. Over 4 years profit has grown −7.8% a year on average. That is 11.5% of the quarter's revenue. The same quarter a year earlier earned $1.2 B. For the full year, FY25 profit was $2.3 B (+228.1% on the year before). Why profit moved: revenue changed +4.0% on a year earlier and the margin moved −0.3 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +699.6% and revenue +10.4%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Nutrien Ltd. make, and is it growing? Nutrien Ltd. reported $10.6 B of revenue in the Jun 2026 quarter, +4.0% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 4 years it has grown −0.9% a year on average. The last full year, FY25, came in at $25.9 B. The last four reported quarters add to $27.3 B. FY25 revenue was $25.9 B, +3.7% on the year before. Recent pace: the last four quarters grew +10.4% on average, against −0.9% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +9.1%, against +2.8% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +73.3%, against +72.0% a year (stabilising). ## How much of every $100 of sales does Nutrien Ltd. keep? Nutrien Ltd.'s operating margin was 17.5% in the Jun 2026 quarter, 0.3 percentage points lower than the same quarter a year ago. Across 5 years it has been between 10.4% and 26.6%. The latest quarter is within that range. Why the margin moved: operating margin changed −0.3 percentage points on the year while gross margin changed −0.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Nutrien Ltd.'s profit turning into cash? Over the last 3 years, 295% of Nutrien Ltd.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $4.0 B of operating cash against $2.3 B of profit. After $1.9 B of spending on assets, $2.1 B was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Nutrien Ltd.'s cash go? Nutrien Ltd. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $6.3 B on assets over the last 3 years. Averaged over those years that is 8.0% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $6.3 B over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Nutrien Ltd.'s P/E ratio, and how does it compare with its own history? Nutrien Ltd.'s P/E is 13.9×, in the middle of its own history: higher than 43% of past readings. Its usual P/E (the middle reading) is 14.7×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +242.6% while the price moved +27.3%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 3 years the price moved +7.2% a year; about +4.5% a year came from earnings growth and about +2.7 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Nutrien Ltd. business getting better or worse? Nutrien Ltd.'s business is giving mixed signals. Growth is slowing from a very fast pace: profit growth has eased from +228.1% at its peak to +73.3%, but the business is still expanding, with ROCE steady at 6.5%. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Nutrien Ltd. earn on its capital? Nutrien Ltd. earned a ROE of 9% in FY25. That is up from a low of 3% in FY24. Its return on capital used (ROIC) is 1.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 8.9% net margin and 0.50× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 8.9% net margin × 0.50× asset turnover × 2.06× leverage (assets divided by equity) ≈ 9.2% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 7.4% − 8.7% = −1.3 percentage points. The 8.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Nutrien Ltd. have too much debt? Nutrien Ltd. has total debt of $12.7 B against shareholder equity of $25.9 B as of Jun 2026, so its debt is 0.49× its equity. Year by year, that ratio went from 0.46 in FY21 to 0.47 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Nutrien Ltd. shareholding pattern? 2.3% of Nutrien Ltd.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Nutrien Ltd. from balance-sheet trouble? For Nutrien Ltd., the Z-score is 1.85. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 1.85 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Nutrien Ltd. rank in its industry? 65.5 out of 100, rank 3 of 11 in Agricultural Inputs, with 75% of the evidence available. Nutrien Ltd. scores 65.5 out of 100 against the 11 companies it is compared with in Agricultural Inputs, ranking 3. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 25.1 + 14.5 + 10.3 + 15.6 = 65.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Nutrien Ltd. compared with? Nutrien Ltd. ranks 3 of 11 Agricultural Inputs companies on the 4-Factor Sector Score, with 65.5 out of 100. 1. [CF Industries Holdings, Inc.](https://www.sectoralpha.in/us/stocks/cf) CF · turning · Sector-leading setup · 85% evidence 86.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.4/35 · Revenue 20% · Profit 61.2% · Operating margin change 15.3 points · 95% evidence Capital efficiency 20.4/25 · ROCE 20.8% · Operating margin 49.3% · 76% evidence Valuation 15.9/20 · P/E 7.9× · PEG 0.24 · 65% evidence Relative strength 18.7/20 · Lead over its industry 38.7% · Lead over S&P 500 1.8% · 1 year 42.4% · 100% evidence · 4 of 12 weeks ahead Exact sum: 31.4 + 20.4 + 15.9 + 18.7 = 86.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [CVR Partners, LP](https://www.sectoralpha.in/us/stocks/uan) UAN · quiet · Sector-leading setup · 85% evidence 82.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.2/35 · Revenue 17.3% · Profit 83% · Operating margin change 14.8 points · 95% evidence Capital efficiency 18.8/25 · ROCE 20.2% · Operating margin 42.4% · 76% evidence Valuation 16.2/20 · P/E 7.4× · PEG 0.06 · 65% evidence Relative strength 15.4/20 · Lead over its industry 31% · Lead over S&P 500 -3.7% · 1 year 19% · 100% evidence · 5 of 12 weeks ahead Exact sum: 32.2 + 18.8 + 16.2 + 15.4 = 82.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. Nutrien Ltd. this page NTR · turning · Most evidence points up · 75% evidence 65.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 9.1% · Profit 73.3% · Operating margin change -0.3 points · 95% evidence Capital efficiency 14.5/25 · ROCE 8.7% · Operating margin 17.5% · 76% evidence Valuation 10.3/20 · P/E 12.7× · PEG n/a · 15% evidence Relative strength 15.6/20 · Lead over its industry 30.3% · Lead over S&P 500 -4.4% · 1 year 21.9% · 100% evidence · 6 of 12 weeks ahead Exact sum: 25.1 + 14.5 + 10.3 + 15.6 = 65.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [The Scotts Miracle-Gro Company](https://www.sectoralpha.in/us/stocks/smg) SMG · turning · Evidence leans up · 85% evidence 63.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 1.3% · Profit 39.6% · Operating margin change -2.4 points · 95% evidence Capital efficiency 17.4/25 · ROCE 22.8% · Operating margin 16.8% · 76% evidence Valuation 11.2/20 · P/E 55× · PEG 1.15 · 65% evidence Relative strength 16.8/20 · Lead over its industry 31.1% · Lead over S&P 500 -4% · 1 year 9.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 17.4 + 11.2 + 16.8 = 63.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) ICL · quiet · Evidence leans up · 85% evidence 58.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 10.9% · Profit -16.9% · Operating margin change 2.6 points · 95% evidence Capital efficiency 11.9/25 · ROCE 8.1% · Operating margin 12.5% · 76% evidence Valuation 14.7/20 · P/E 21.1× · PEG 0.11 · 65% evidence Relative strength 11.4/20 · Lead over its industry 5.7% · Lead over S&P 500 -22.5% · 1 year -22.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 11.9 + 14.7 + 11.4 = 58.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Intrepid Potash, Inc.](https://www.sectoralpha.in/us/stocks/ipi) IPI · quiet · Evidence leans down · 67% evidence 46.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 7.8% · Profit n/a · Operating margin change -0.8 points · 71% evidence Capital efficiency 7.1/25 · ROCE 2.9% · Operating margin 2.5% · 76% evidence Valuation 10.0/20 · P/E 16.4× · PEG n/a · 15% evidence Relative strength 11.9/20 · Lead over its industry 15.8% · Lead over S&P 500 -15.7% · 1 year 22% · 100% evidence · 3 of 12 weeks ahead Exact sum: 17.3 + 7.1 + 10 + 11.9 = 46.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Del Monte Corporation](https://www.sectoralpha.in/us/stocks/dmc) DMC · quiet · Evidence leans down · 75% evidence 40.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue -0.2% · Profit -77.3% · Operating margin change -1.8 points · 95% evidence Capital efficiency 9.2/25 · ROCE 5.6% · Operating margin 3.9% · 76% evidence Valuation 9.4/20 · P/E 40.9× · PEG n/a · 15% evidence Relative strength 10.8/20 · Lead over its industry 2.3% · Lead over S&P 500 -25.6% · 1 year -27.2% · 100% evidence · 1 of 12 weeks ahead Exact sum: 11.2 + 9.2 + 9.4 + 10.8 = 40.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) MOS · quiet · Evidence leans down · 75% evidence 35.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.8/35 · Revenue 8.8% · Profit -168.1% · Operating margin change -8.2 points · 95% evidence Capital efficiency 6.6/25 · ROCE 2.5% · Operating margin -0.1% · 76% evidence Valuation 10.6/20 · P/E 9× · PEG n/a · 15% evidence Relative strength 8.5/20 · Lead over its industry 0.3% · Lead over S&P 500 -27% · 1 year -28% · 100% evidence · 3 of 12 weeks ahead Exact sum: 9.8 + 6.6 + 10.6 + 8.5 = 35.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Corteva, Inc.](https://www.sectoralpha.in/us/stocks/ctva) CTVA · basing · Most evidence points down · 75% evidence 33.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.8/35 · Revenue -40.3% · Profit -132.5% · Operating margin change -14.4 points · 95% evidence Capital efficiency 12.3/25 · ROCE 11.6% · Operating margin 12.8% · 76% evidence Valuation 9.1/20 · P/E 41.9× · PEG n/a · 15% evidence Relative strength 0.0/20 · Lead over its industry -77.3% · Lead over S&P 500 -83.9% · 1 year -81.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.8 + 12.3 + 9.1 + 0 = 33.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [FMC Corporation](https://www.sectoralpha.in/us/stocks/fmc) FMC · quiet · Most evidence points down · 75% evidence 24.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 4.3/35 · Revenue -21.3% · Profit -2802.9% · Operating margin change -3.7 points · 95% evidence Capital efficiency 6.2/25 · ROCE 1.5% · Operating margin 11.8% · 76% evidence Valuation 8.8/20 · P/E 52.7× · PEG n/a · 15% evidence Relative strength 4.7/20 · Lead over its industry -36.3% · Lead over S&P 500 -54.3% · 1 year -56.5% · 100% evidence · 1 of 12 weeks ahead Exact sum: 4.3 + 6.2 + 8.8 + 4.7 = 24 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Glass House Brands Inc.](https://www.sectoralpha.in/us/stocks/glas) GLAS · quiet · Most evidence points down · 75% evidence 17.7 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Agricultural Inputs](https://www.sectoralpha.in/us/sectors/agricultural-inputs), all 11 compared on one page. ## Which companies are close to Nutrien Ltd. in size? Nutrien Ltd. is the largest of 11 Agricultural Inputs companies on Sector Alpha by market value (scores of 3 November 2026). It is the largest. Just below it: CF Industries Holdings, Inc., Corteva, Inc., The Mosaic Company, ICL Group, The Scotts Miracle-Gro Company and Del Monte Corporation. ### Agricultural Inputs companies close in size

1. Nutrien Ltd. $33.1 billion
2. [CF Industries Holdings, Inc.](https://www.sectoralpha.in/us/stocks/cf) $17.7 billion
3. [Corteva, Inc.](https://www.sectoralpha.in/us/stocks/ctva) $7.9 billion
4. [The Mosaic Company](https://www.sectoralpha.in/us/stocks/mos) $5.9 billion
5. [ICL Group Ltd](https://www.sectoralpha.in/us/stocks/icl) $5.6 billion
6. [The Scotts Miracle-Gro Company](https://www.sectoralpha.in/us/stocks/smg) $3.6 billion
7. [Del Monte Corporation](https://www.sectoralpha.in/us/stocks/dmc) $1.3 billion

[All 11 Agricultural Inputs companies, largest first](https://www.sectoralpha.in/us/sectors/agricultural-inputs#all-companies)

### Companies close in size in other industries

1. [Ecopetrol S.A.](https://www.sectoralpha.in/us/stocks/ec) $33.6 billion · Oil & Gas Integrated
2. [Mettler-Toledo International Inc.](https://www.sectoralpha.in/us/stocks/mtd) $33.6 billion · Diagnostics & Research
3. Nutrien Ltd. $33.5 billion
4. [Genmab A/S](https://www.sectoralpha.in/us/stocks/gmab) $33.1 billion · Biotechnology
5. [Centene Corporation](https://www.sectoralpha.in/us/stocks/cnc) $32.9 billion · Healthcare Plans

## What else do people ask about Nutrien Ltd.? ### What were Nutrien Ltd. Ltd.'s latest quarterly results? Nutrien Ltd. reported revenue of $10.6 B and net profit of $1.2 B for the Jun 2026 quarter. Revenue rose 4.0% and profit fell 0.6% compared with a year earlier. Earnings per share were $2.53. The operating margin was 17.5%, 0.3 percentage points lower than a year earlier (as of 3 November 2026). ### What is Nutrien Ltd. Ltd.'s market cap? Nutrien Ltd.'s market capitalisation is $33.1 B at a stock price of $69.32. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Nutrien Ltd. Ltd. performing? Nutrien Ltd.'s share price has been moving sideways for 3 weeks. In its latest quarter, revenue rose 4.0% and profit fell 0.6% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running (as of 3 November 2026). ### Will Nutrien Ltd. Ltd.'s stock price go up? This page does not forecast Nutrien Ltd.'s stock price. What it shows instead: the stock price is $69.32, and it has been moving sideways for 3 weeks. Its P/E of 13.9× is higher than 43% of its own last 5 years (as of 3 November 2026). ### Is Nutrien Ltd. Ltd.'s profit real cash? Yes, over the last 3 years, 295% of Nutrien Ltd.'s reported profit came in as cash from operations. The latest year was lower at 174%, so the trend is worth watching. In FY25, operating cash was $4.0 B against reported profit of $2.3 B. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Nutrien Ltd. Ltd. in its business cycle? Nutrien Ltd.'s FY25 operating margin was 13.4%, against a 5-year range of 10.4% to 26.6%: the low end of its own range, which is often where recoveries start. The latest quarter was 17.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Nutrien Ltd. Ltd. story? The main question: yearly earnings per share moved +242.6% while the share price moved +27.3%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Nutrien Ltd. Ltd. a stock worth studying right now? What the numbers show: Nutrien Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.